December 11, 2008
GENFIT evaluates GFT505 on its pre-diabetic patients target population
November 28, 2008
Therapeutic potential of GFT505 is demonstrated in the treatment of cardiovascular risk associated with pre-diabetes
January 12-15, 2009San Francisco - USA
January 20 - 25, 2009
Banff, Alberta – Canada
Happy New Year!
